Key result
Monitoring oxidative stress biomarkers in chronic kidney disease may improve non-invasive diagnostic methods and help better understand disease etiology, though antioxidant therapies require further clinical validation.
Why the study?
Can monitoring oxidative stress-associated biomarkers support diagnosis, prognostication, and treatment initiation in patients with chronic kidney disease?
Can monitoring oxidative stress-associated biomarkers support diagnosis, prognostication, and treatment initiation in patients with chronic kidney disease?
Oxidative stress biomarkers may serve as non-invasive diagnostic and prognostic tools in chronic kidney disease, potentially reducing the need for renal biopsy.
May support non-invasive CKD monitoring; leaves open clinical adoption and antioxidant efficacy pending validation trials.
Exaggerated oxidative stress (OS) is usually considered as a disturbance in regular function of an organism. The excessive levels of OS mediators may lead to major damage within the organism's cells and tissues. Therefore, the OS-associated biomarkers may be considered as new diagnostic tools of various diseases. In nephrology, researchers are looking for alternative methods replacing the renal biopsy in patients with suspicion of chronic kidney disease (CKD). Currently, CKD is a frequent health problem in world population, which can lead to progressive loss of kidney function and eventually to end-stage renal disease. The course of CKD depends on the primary disease. It is assumed that one of the factors influencing the course of CKD might be OS. In the current work, we review whether monitoring the OS-associated biomarkers in nephrology patients can support the decision-making process regarding diagnosis, prognostication and treatment initiation.
No takes yet. Share an insight, caveat, or question.
Krata et al. (2017) conducted a review in Chronic kidney disease. Oxidative stress biomarkers and antioxidant therapies was evaluated. Monitoring oxidative stress biomarkers in chronic kidney disease may improve non-invasive diagnostic methods and help better understand disease etiology, though antioxidant therapies require further clinical validation.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: